Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update

Ciudin, Andreea; Baker, Jennifer; Belančić, Andrej; Busetto, Luca; Dicker, Dror; Fábryová, Ľubomíra; Frühbeck, Gema; Goossens, Gijs; Gordon, Jason; Monami, Matteo; Sbraccia, Paolo; Martinez-Tellez, Borja; YUMUK, VOLKAN; McGowan, Barbara

doi:10.1038/s41591-026-04397-4

Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update

Ciudin A., Baker J. L., Belančić A., Busetto L., Dicker D., Fábryová Ľ., ...Daha Fazla

Nature Medicine, cilt.32, sa.6, ss.1962-1966, 2026 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Teknik Not
Cilt numarası: 32 Sayı: 6
Basım Tarihi: 2026
Doi Numarası: 10.1038/s41591-026-04397-4
Dergi Adı: Nature Medicine
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Chemical Abstracts Core, EMBASE, MEDLINE, Nature Index
Sayfa Sayıları: ss.1962-1966
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

This 2026 update integrates emerging trial evidence — particularly for weight loss and liver disease — to refine EASO’s treatment algorithm for obesity management.